Atlas Trials

Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir

Clinical trial NCT05108051 · COMPLETED

Trial details

NCT number
NCT05108051
Sponsor
Guangdong Raynovent Biotech Co., Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug-drug Interaction
Start date
2020-11-19
Primary completion
2021-03-17
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.